2022 Q2 Form 10-Q Financial Statement
#000165495422006967 Filed on May 16, 2022
Income Statement
Concept | 2022 Q2 | 2022 Q1 | 2021 Q4 |
---|---|---|---|
Revenue | $636.6K | $87.20K | $26.40K |
YoY Change | 213.62% | ||
Cost Of Revenue | $319.0K | $41.08K | $9.790K |
YoY Change | 358.89% | 3188.87% | |
Gross Profit | $317.7K | $46.12K | $16.61K |
YoY Change | 137.98% | 5189.22% | |
Gross Profit Margin | 49.9% | 52.89% | 62.92% |
Selling, General & Admin | $627.1K | $551.7K | $178.2K |
YoY Change | -27.08% | 5.5% | -59.5% |
% of Gross Profit | 197.41% | 1196.24% | 1072.79% |
Research & Development | $1.635M | $1.577M | $1.274M |
YoY Change | |||
% of Gross Profit | 514.65% | 3420.18% | 7669.18% |
Depreciation & Amortization | $1.210M | $1.169M | |
YoY Change | 135.03% | ||
% of Gross Profit | 380.93% | 2534.08% | |
Operating Expenses | $2.262M | $2.129M | $1.452M |
YoY Change | -363.01% | 307.12% | 230.01% |
Operating Profit | -$1.944M | -$2.083M | -$1.435M |
YoY Change | 167.61% | 298.97% | 226.23% |
Interest Expense | $3.417K | $15.88K | -$9.330K |
YoY Change | 0.0% | -258.83% | -6.7% |
% of Operating Profit | |||
Other Income/Expense, Net | $9.060K | $146.00 | $0.00 |
YoY Change | -101.05% | ||
Pretax Income | -$1.954M | -$2.100M | -$1.445M |
YoY Change | 160.62% | 296.21% | 221.06% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$1.954M | -$2.100M | -$1.445M |
YoY Change | 160.62% | 293.23% | 221.06% |
Net Earnings / Revenue | -306.94% | -2408.14% | -5472.61% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$203.0K | -$218.2K | -$96.18K |
COMMON SHARES | |||
Basic Shares Outstanding | 144.4M shares | 142.4M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q2 | 2022 Q1 | 2021 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $1.754M | $1.871M | $1.752M |
YoY Change | 189.11% | 18613.5% | 8657.5% |
Cash & Equivalents | $1.754M | $1.871M | $1.751M |
Short-Term Investments | |||
Other Short-Term Assets | $1.275M | $813.9K | $466.2K |
YoY Change | 935.43% | 2613.03% | 832.4% |
Inventory | $670.5K | $337.8K | $183.4K |
Prepaid Expenses | |||
Receivables | $0.00 | ||
Other Receivables | |||
Total Short-Term Assets | $3.699M | $3.023M | $2.218M |
YoY Change | 325.42% | 7457.65% | 2802.25% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $1.503M | $1.420M | $1.188M |
YoY Change | 6456.84% | 36455.92% | |
Goodwill | |||
YoY Change | |||
Intangibles | $37.33M | ||
YoY Change | 20566.34% | ||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $124.7K | $79.60K | $87.57K |
YoY Change | 61.67% | ||
Total Long-Term Assets | $36.71M | $37.71M | $38.60M |
YoY Change | 85.87% | 20851.78% | 20894.72% |
TOTAL ASSETS | |||
Total Short-Term Assets | $3.699M | $3.023M | $2.218M |
Total Long-Term Assets | $36.71M | $37.71M | $38.60M |
Total Assets | $40.41M | $40.74M | $40.82M |
YoY Change | 95.97% | 18416.48% | 15583.34% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $109.1K | $1.005M | |
YoY Change | 569.91% | ||
Accrued Expenses | $2.598M | $1.340M | $28.67K |
YoY Change | 12532.33% | 282.74% | 18.5% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $1.013M | $1.013M | $3.590M |
YoY Change | -40.79% | 322.25% | 277.89% |
Long-Term Debt Due | $3.377M | $3.377M | $3.380M |
YoY Change | 120.69% | 267.01% | |
Total Short-Term Liabilities | $6.988M | $5.730M | $30.59M |
YoY Change | 194.1% | 281.97% | 2684.97% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $27.40M | $26.90M | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $18.32K | $24.15K | $30.26K |
YoY Change | -54.85% | ||
Total Long-Term Liabilities | $27.42M | $26.92M | $30.26K |
YoY Change | 67466.1% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $6.988M | $5.730M | $30.59M |
Total Long-Term Liabilities | $27.42M | $26.92M | $30.26K |
Total Liabilities | $34.41M | $32.65M | $30.63M |
YoY Change | 1323.64% | 2076.91% | 2687.72% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$14.16M | -$12.21M | -$10.11M |
YoY Change | 88.74% | 62.52% | |
Common Stock | $1.444M | $1.444M | |
YoY Change | 1.48% | 243.22% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $6.006M | -$8.083M | $10.20M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $40.41M | $40.74M | $40.82M |
YoY Change | 95.97% | 18416.48% | 15583.34% |
Cashflow Statement
Concept | 2022 Q2 | 2022 Q1 | 2021 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.954M | -$2.100M | -$1.445M |
YoY Change | 160.62% | 293.23% | 221.06% |
Depreciation, Depletion And Amortization | $1.210M | $1.169M | |
YoY Change | 135.03% | ||
Cash From Operating Activities | -$229.3K | -$1.390M | -$680.8K |
YoY Change | 434.03% | 556.42% | 656.48% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$424.6K | $135.9K | -$143.8K |
YoY Change | 1721.36% | -1537.9% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $135.9K | -$135.9K | $6.610K |
YoY Change | 339650.0% | ||
Cash From Investing Activities | -$288.7K | -$135.9K | -$137.2K |
YoY Change | 1139.95% | 1271.8% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 545.0K | $1.645M | 1.864M |
YoY Change | -16.23% | 727.12% | 6114.13% |
NET CHANGE | |||
Cash From Operating Activities | -229.3K | -$1.390M | -680.8K |
Cash From Investing Activities | -288.7K | -$135.9K | -137.2K |
Cash From Financing Activities | 545.0K | $1.645M | 1.864M |
Net Change In Cash | 27.08K | $119.1K | 1.046M |
YoY Change | -95.37% | -1025.52% | -1594.61% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$229.3K | -$1.390M | -$680.8K |
Capital Expenditures | -$424.6K | $135.9K | -$143.8K |
Free Cash Flow | $195.3K | -$1.526M | -$537.0K |
YoY Change | -1095.41% | 437.04% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
144379308 | shares |
CY2022Q1 | us-gaap |
Notes Payable
NotesPayable
|
1013405 | USD |
CY2021Q4 | us-gaap |
Notes Payable
NotesPayable
|
213405 | USD |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1443793 | USD |
CY2022Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2022Q1 | aimd |
Convertible Notes Payable Noncurrent
ConvertibleNotesPayableNoncurrent
|
26900000 | USD |
CY2021Q4 | aimd |
Convertible Notes Payable Noncurrent
ConvertibleNotesPayableNoncurrent
|
0 | USD |
CY2022Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
24152 | USD |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
30255 | USD |
CY2022Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
144379308 | shares |
CY2022Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
18899873 | USD |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
18856430 | USD |
CY2022Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-12208811 | USD |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-10108916 | USD |
CY2022Q1 | aimd |
Translation Adjustment Liability
TranslationAdjustmentLiability
|
-52259 | USD |
CY2021Q4 | aimd |
Translation Adjustment Liability
TranslationAdjustmentLiability
|
5800 | USD |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8082596 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10197107 | USD |
CY2022Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
40736264 | USD |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
40822161 | USD |
CY2022Q1 | us-gaap |
Revenues
Revenues
|
87200 | USD |
CY2022Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
551730 | USD |
CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
2129184 | USD |
CY2021Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
522981 | USD |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2083062 | USD |
CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-522109 | USD |
CY2022Q1 | us-gaap |
Interest Revenue Expense Net
InterestRevenueExpenseNet
|
-16687 | USD |
CY2021Q1 | us-gaap |
Interest Revenue Expense Net
InterestRevenueExpenseNet
|
-11897 | USD |
CY2022Q1 | us-gaap |
Other Expenses
OtherExpenses
|
146 | USD |
CY2021Q1 | us-gaap |
Other Expenses
OtherExpenses
|
0 | USD |
CY2022Q1 | aimd |
Total Non Operating Income And Expenses
TotalNonOperatingIncomeAndExpenses
|
-16833 | USD |
CY2021Q1 | aimd |
Total Non Operating Income And Expenses
TotalNonOperatingIncomeAndExpenses
|
-11897 | USD |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2099895 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-534006 | USD |
CY2022Q1 | aimd |
Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
|
-0.01 | |
CY2021Q1 | aimd |
Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
|
-0.01 | |
CY2022Q1 | aimd |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
144379308 | shares |
CY2021Q1 | aimd |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
42066172 | shares |
CY2022Q1 | aimd |
Net Loss
NetLoss
|
-2099895 | USD |
CY2021Q1 | aimd |
Net Loss
NetLoss
|
-534006 | USD |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
58059 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
0 | USD |
CY2022Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2157954 | USD |
CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-534006 | USD |
CY2022Q1 | us-gaap |
Dividends Share Based Compensation
DividendsShareBasedCompensation
|
43443 | USD |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2099895 | USD |
CY2022Q1 | aimd |
Translation Adjustment
TranslationAdjustment
|
-58059 | USD |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8082596 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-838278 | USD |
CY2021Q1 | us-gaap |
Dividends Share Based Compensation
DividendsShareBasedCompensation
|
94105 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-534006 | USD |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1278179 | USD |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-2099895 | USD |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-534006 | USD |
CY2022Q1 | us-gaap |
Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
|
1168773 | USD |
CY2021Q1 | us-gaap |
Cost Depreciation Amortization And Depletion
CostDepreciationAmortizationAndDepletion
|
3905 | USD |
CY2022Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
43443 | USD |
CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
94105 | USD |
CY2022Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
-337805 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1644884 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
198869 | USD |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
119096 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-12868 | USD |
CY2022Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
754 | USD |
CY2021Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
0 | USD |
CY2021Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
3024 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
297707 | USD |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1751499 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
22245 | USD |
CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1871349 | USD |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9377 | USD |
CY2022Q1 | aimd |
Issuance Of Convertible Notes For Payables Related Party
IssuanceOfConvertibleNotesForPayablesRelatedParty
|
26000000 | USD |
CY2021Q1 | aimd |
Issuance Of Convertible Notes For Payables Related Party
IssuanceOfConvertibleNotesForPayablesRelatedParty
|
0 | USD |
CY2022Q1 | us-gaap |
Notes Issued1
NotesIssued1
|
50000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-18254 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
133302 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
202981 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1389889 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-211737 | USD |
CY2022Q1 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
135899 | USD |
CY2021Q1 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
0 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-135899 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | USD |
CY2022Q1 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
850000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
236854 | USD |
CY2022Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
800000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
0 | USD |
CY2022Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
CY2021Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
37985 | USD |
CY2022Q1 | aimd |
Payments Of Lease Liabilities
PaymentsOfLeaseLiabilities
|
5116 | USD |
CY2021Q1 | aimd |
Payments Of Lease Liabilities
PaymentsOfLeaseLiabilities
|
0 | USD |
CY2021Q1 | us-gaap |
Notes Issued1
NotesIssued1
|
0 | USD |
CY2022Q1 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
202002 | USD |
CY2021Q1 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
0 | USD |
CY2022Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q1 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
4389931 | USD |
CY2021 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
3589931 | USD |
CY2022Q1 | aimd |
Total Convertible And Nonconvertiblepayment
TotalConvertibleAndNonconvertiblepayment
|
0 | USD |
CY2021 | aimd |
Non Convertible Notes Payable Related Party
NonConvertibleNotesPayableRelatedParty
|
129405 | USD |
CY2022Q1 | aimd |
Non Convertible Notes Payable Related Party Addition
NonConvertibleNotesPayableRelatedPartyAddition
|
800000 | USD |
CY2022Q1 | aimd |
Non Convertible Notes Payable Related Party
NonConvertibleNotesPayableRelatedParty
|
929405 | USD |
CY2022Q1 | aimd |
Non Convertible Notes Payable Related Party Accrued Interest
NonConvertibleNotesPayableRelatedPartyAccruedInterest
|
1489 | USD |
CY2021 | aimd |
Total Non Convertible Notes Payable
TotalNonConvertibleNotesPayable
|
213405 | USD |
CY2022Q1 | aimd |
Total Non Convertible Notes Payable Addition
TotalNonConvertibleNotesPayableAddition
|
800000 | USD |
CY2022Q1 | aimd |
Total Non Convertible Notes Payable
TotalNonConvertibleNotesPayable
|
1013405 | USD |
CY2022Q1 | aimd |
Total Non Convertible Notes Payable Accrued Interest
TotalNonConvertibleNotesPayableAccruedInterest
|
5016 | USD |
CY2021 | aimd |
Total Convertible And Nonconvertible
TotalConvertibleAndNonconvertible
|
3589931 | USD |
CY2022Q1 | aimd |
Total Convertible And Nonconvertibleaddition
TotalConvertibleAndNonconvertibleaddition
|
800000 | USD |
CY2022Q1 | aimd |
Total Convertible And Nonconvertible
TotalConvertibleAndNonconvertible
|
4389931 | USD |
CY2022Q1 | aimd |
Total Convertible And Nonconvertiblepaymentaccrued
TotalConvertibleAndNonconvertiblepaymentaccrued
|
44556 | USD |
CY2022Q1 | aimd |
Convertible Notes Amount
ConvertibleNotesAmount
|
3000000 | USD |
CY2022Q1 | aimd |
Principal Amount Property
PrincipalAmountProperty
|
800000 | USD |
CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
15883 | USD |
CY2021 | us-gaap |
Interest Expense
InterestExpense
|
11897 | USD |
CY2022Q1 | aimd |
Cumulative Accrued Interest
CumulativeAccruedInterest
|
44556 | USD |
CY2021Q4 | aimd |
Cumulative Accrued Interest
CumulativeAccruedInterest
|
28673 | USD |
CY2022Q1 | aimd |
Non Current Convertible Notes Payable
NonCurrentConvertibleNotesPayable
|
26900000 | USD |
aimd |
Non Current Convertible Notes Payable
NonCurrentConvertibleNotesPayable
|
0 | USD | |
CY2022Q1 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
26000000 | USD |
CY2022Q1 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.01 | |
CY2022Q1 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
26000000 | USD |
CY2022Q1 | aimd |
Principal Amount Property
PrincipalAmountProperty
|
26000000 | USD |
CY2022Q1 | us-gaap |
Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
|
4355931 | USD |
CY2021Q4 | us-gaap |
Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
|
3505931 | USD |
CY2022Q1 | aimd |
Covid Ninteen Antigen Rapid Test Kits Amount
CovidNinteenAntigenRapidTestKitsAmount
|
386412 | USD |
CY2022Q1 | aimd |
Research And Development Expense1
ResearchAndDevelopmentExpense1
|
167422 | USD |
CY2022Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
109131 | USD |
CY2022Q1 | aimd |
Convertible Notes Amount
ConvertibleNotesAmount
|
3000000 | USD |